Arns Beatriz, Vieceli Tarsila, Gomes Eduardo, Scherer Mariana Horn, Nakashima Luisa, Santos Maria Luisa, Hepp Ronara Blos, Greinert Fernanda, Rigatto Maria Helena
Hospital de Clínicas de Porto Alegre, Programa de Pós-Graduação em Ciências Médicas, Porto Alegre, RS, Brazil.
Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Braz J Infect Dis. 2025 May-Jun;29(3):104519. doi: 10.1016/j.bjid.2025.104519. Epub 2025 Mar 28.
Syphilis is a highly prevalent sexually transmitted infection worldwide. Patients living with Human Immunodeficiency Virus (HIV) have a higher risk of developing neurosyphilis. Actual guidelines advise to proceed with lumbar puncture only if neurologic symptoms are present. However, asymptomatic neurosyphilis patients are not rare in the HIV population and other risk factors should be defined to guide screening.
We performed a retrospective cohort to evaluate risk factors related to neurosyphilis in HIV patients. Adults with HIV infection and laboratory confirmed syphilis between 2011 and 2021 were included. Patients with no record of syphilis treatment, VDRL titers ≤ 1:4, other neurologic diseases or non-HIV related immunological impairment were excluded. The patients were followed for 2-years after syphilis diagnosis.
One-hundred and forty patients (190 syphilis episodes) were included, with mean age of 45.0 ± 9.2-years-old, 111 (79.3 %) were male, 48 (25.8 %) had CD4 count ≤ 350 cells/mm at syphilis diagnosis (median: 522.5 cells/mm; IQR: 315.5‒703.5), 127 (66.8 %) of 172 had a HIV viral load ≤ 400 copies/mm and median serum VDRL titer was 1:64 (IQR: 1:16‒1:128). In multivariate analysis, serum VDRL titers ≥ 1:32 and the presence of neurologic symptoms were associated with neurosyphilis, while HIV viral load ≤ 400 copies/mm was a protective factor.
In addition to the presence of neurological symptoms, HIV viral load > 400 copies/mm and VDRL titers ≥ 1:32 were shown to be risk factors for neurosyphilis in this study and diagnostic lumbar puncture should be considered in these cases.
梅毒是一种在全球范围内高度流行的性传播感染。感染人类免疫缺陷病毒(HIV)的患者发生神经梅毒的风险更高。现行指南建议仅在出现神经系统症状时才进行腰椎穿刺。然而,无症状神经梅毒患者在HIV人群中并不罕见,应确定其他风险因素以指导筛查。
我们进行了一项回顾性队列研究,以评估HIV患者中与神经梅毒相关的风险因素。纳入2011年至2021年间确诊感染HIV且实验室确诊梅毒的成年人。排除无梅毒治疗记录、VDRL滴度≤1:4、其他神经系统疾病或非HIV相关免疫功能损害的患者。梅毒诊断后对患者进行了2年的随访。
纳入140例患者(190次梅毒发作),平均年龄45.0±9.2岁,男性111例(79.3%),梅毒诊断时48例(25.8%)的CD4细胞计数≤350个/mm³(中位数:522.5个/mm³;四分位间距:315.5‒703.5),172例中的127例(66.8%)HIV病毒载量≤400拷贝/mm³,血清VDRL滴度中位数为1:64(四分位间距:1:16‒1:128)。多因素分析显示,血清VDRL滴度≥1:32和存在神经系统症状与神经梅毒相关,而HIV病毒载量≤400拷贝/mm³是一个保护因素。
本研究表明,除存在神经系统症状外,HIV病毒载量>400拷贝/mm³和VDRL滴度≥1:32是神经梅毒的风险因素,在这些情况下应考虑进行诊断性腰椎穿刺。